US3926736A - Enzymatic ethanol assay - Google Patents
Enzymatic ethanol assay Download PDFInfo
- Publication number
- US3926736A US3926736A US502210A US50221074A US3926736A US 3926736 A US3926736 A US 3926736A US 502210 A US502210 A US 502210A US 50221074 A US50221074 A US 50221074A US 3926736 A US3926736 A US 3926736A
- Authority
- US
- United States
- Prior art keywords
- composition
- buffer
- trapping agent
- assay
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
Definitions
- a useful method of determining the'ethanol content of fluids. and particularly of body fluids when used as a test of recent alcohol ingestion utilizes the enzymatic reaction whereby ethanol is transformed to acetaldehyde by the action of alcohol dehydrogenase in which nicotinamide adenine dinucleotide (NAD) serves a a coenzyme and in turn is reduced to its reduced form (NADH).
- NAD nicotinamide adenine dinucleotide
- NADH nicotinamide adenine dinucleotide
- the course and extent of the reaction are determined by ultraviolet colorimetry at 340 nanometers. at which wave length NAD does not absorb the ultraviolet light but NADH does.
- a useful trapping agent has been found to be aminooxyacetic acid. described in connection with an ethanol assay in US. Pat. No. 3.493.467. of William Drell et al. and in Clinical Chemistry 16 402-407 (1970). in an article by Jones. Gerber and Drell.
- the two compounds are 2-amino-2-hydroxymethyl)- 1.3-propanediol'. and 2-amino-2-methyl- 1 .3- propanediol.
- the first of these is commonly known as "Trisamino”; and may also be namedas tris(hydroxymethyhaminomethane. it is entered on pagel083 of the Merck index. 8th edition 1968. under the generic" name of tromethamine.
- the second compound recited appears on page 57 of the Merck Index under the Geneva nomenclature given above. Both of these compounds. which as will be observed. differ only by one hydroxyl radical. give a pH somewhat in excess of 10 in diluted aqueous solution. When partially neutralized with acid. such as hydrochloric. to a pH within the general range of 8.9 to,9.2 then they behave as buffers with a good buffer capacity. and likewise exhibit the trapping effect already mentioned.
- any of the usual methods common in this art for putting together the individual components so as to form the inventive combination may be used.
- all of the components may be put into a single solution. which may conveniently be water. and this may then be freeze dried followed by grinding or sieving so as to produce a dry powdered composition.
- the components may be intimately mixed together in their dry state, for which ball milling is convenient. This brings about a homogeneous composition in the form of a fine powder.
- enhanced stability may be given to the combination by supplying it in two moieties. This may conveniently comprise the NAD as one moiety and the balance of the components as the second. In order to carry out the assay. preselected quantities of each are dissolved in water and mixed together.
- the fluid to be assayed for its ethanol content is added in a preselected volume. and the absorbance of the solution before and after incubation under selected conditions. typically for 8 to 10 minutes at 30 C. is determined. A blank is carried through the procedure in the usual fashion so that appropriate correction may be automatically made. The details of the actual absorbance procedure follow the customary sequence. and need not be set forth in detail here.
- a typical and recommendable protocol may be found in the Jones et al. 1970 article and in the Drell et al. patent cited here and above. both of which are included herein by reference. Of course. when the components are not provided as two moieties. but rather as a single mixture, then a preselected quantity of the single mixture is dissolved in water and the assay carried out as already described.
- a dry blend is made of the following substances in the quantities named:
- Example I The composition and procedures of Example I are carried out as stated except that in place of 842 mg'of 2-amino-2-hydroxymethyl- 1.3-propanediol there are used 421 mg of Z-aminO-Z-hydroxymethyl-1.3- propanediol together with 369 mg of 2-amino-2-meth- EXAMPLE 4.1 I
- Example 1 The composition and procedures of Example 1 are carried out as stated with the exception that the ethylene diamine tetra-acetic acid. tetrasodium salt. is omit- EXAMPLE 5."
- Example 2 The-compositionand procedures of Example 2 are carried out as stated with the exception that the ethylene diamine tetra-acetic acid. tetrasodiu-m salt. is omitted.
- Example 3 The composition and procedures of Example 3are carried out as stated with. the exception that the ethylene diamine tetra-acetic acid. tetrasodium salt. is omitted.
- Example l The composition of Example l is prepared and dissolved in 13.5 ml of distilled water. The solution is then freeze-dried to yield a dry. homogeneous mixture. which is used for carrying out the assay'as already described in Example I. v
- Example 7 The procedure of Example 7 is carried out as stated therein except that the composition of Example 4 instead-of the composition of Example 1 is used.
- the buffer/trapping agent should be present in the assay mixture solution at aconcentration of at least 0.3 molar. An excess does no harm. but is of course waste- 5. heavy metal sequestrant .ful. A practical upper limit is 3 molar. although even this may be exceeded without affecting the inventive assay.
- both species of the buffer/trapping agent used in accordance with the invention have a natural-alkalinity somewhat higher than the optimum pH for the enzymatic reactionconcer'ned so that l in clude an acid in the inventive composition.
- a solid acid is desirable. particularly one that does not have any water of crystallization in the molecule.
- Succinic acid is well adapted for this purpose and in general'[ find it best.
- Tartaric acid inany of its isomeric forms may likewise be used as well as other solid acids. such as. for example. fumaric. gluconic. citric. malic and the like.
- the assay composition is prepared by a preliminary dissolution and then freeze-dried.
- the acids already named may be used and non-solid'acids as well.such as hydrochloric. sulphuric. phosphoric and the like.
- the relative proportions of acid and buffer/trapping agent are selected-to give a pH in the range already stated when .the solid assay mixture is dissolved in water in such proportionasto give a molarity of at least 0.3 for the buffer/trapping agent.
- the weight proportion will vary depending on the particular acid or mixture ofacids selected. A typical weight ratio appears in the examples.
- the heavy metal sequestrant which l prefer and find best is ethylene diamine tetra-acetic acid, which may be added as an acid or as any of its sodium salts.
- the amount used is small in any case. so that whether it is added as the acid or salt form is not critical particularly since any acid contribution therefrom will automatically be compensated for when a determination-is made of. the quantity of the selected acid needed to achieve a pH in the stated range.
- Many other heavy metal sequestrants may be employed. such as. for example. diethyline triamine penta-acetic acid; S-hydroxyquinoline; orthophenanthroline; bipyridyl; and many others known to those skilled in the art of coordination chemistry.
- the sequestrant may typically be employed in quantities of from about 1 to 5 parts per 100 of the buffer/trapping agent.
- composition of matter useful as a reagent in determining the ethanol content of body fluids consisting essentially of:
- a buffer/acetaldehyde-trapping agent selected from the group consisting of Z-amino-Z-hydroxymethyll .3-propanediol, 2-amino-2-methyl- 1,3- propanediol and mixtures thereof;
- composition of claim 1 wherein said composition is present in the form of two moieties. one containing said coenzyme and the other the balance of the recited components.
- composition of claim 1 which includes a heavy metal sequestering agent.
- composition of claim 3 in which said sequestering agent is ethylene diamine tetra-acetic acid. or a sodium salt thereof.
- An assay solution useful in the determination of the ethanol content of body fluids consisting essentially of the composition of claim 1 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of at least 0.3 molar.
- composition in accordance with claim 1 wherein, for each 6.99 millimoles of said buffer/trapping agent, l6 18 mg of NAD; and from 200 220 LU. of alcohol dehydrogenase are present.
- An assay solution useful in the determination of the ethanol content of body fluids consisting essentially of the composition of claim 6 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of approximately at least 0.3 molar.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
This invention provides an improved enzymatic assay for ethanol in body fluids, whereby a single substance acts simultaneously as a buffer and as a trapping agent for one of the products of the enzymatic reaction.
Description
United States Patent Bucolo Dec. 16, 1975 ENZYMATIC ETHANOL ASSAY 3,493.467 2/1970 Drell et a1 .1 195/1035 R [75] n entor: Giovanni Bucolo, kvington NYI 3,764,478 10/1973 Bergmeyer et al l95/lO3.5 R
[73] Assignee: Calbiochem, La Jolla, Calif Primary Examiner A Louis Menace [22] Filed: Aug. 30, 1974 Assistant ExaminerC. A. Fan
L PP Nol: 0 A1101 ney, Agent, or Fnm Delmar H arsen [52] US. Cl 195/1035 R ABSTRACT [51] Int. Cl. ClZK l/04 This invention provides an improved enzymatic assay [58] Field Search 195/1035 R; 23/230 B for ethanol in body fluids, whereby a single substance [56] References (med acts simultaneously as a buffer and as a trapping agent for one of the products of the enzymatic reaction. UNITED STATES PATENTS 3,413,198 11/1968 Deutsch 195/1035 R 7 Claims, N0 Drawings ENZYMATIC ETHANOL ASSAY This invention relates to an improvement in the enzymatic assay of ethanol. particularly in body fluids such as saliva. serum and urine. wherein a single chemical compound serves the dual function of a buffer and a trapping agent by which one of the products of the reaction involved is removed.
A useful method of determining the'ethanol content of fluids. and particularly of body fluids when used as a test of recent alcohol ingestion. utilizes the enzymatic reaction whereby ethanol is transformed to acetaldehyde by the action of alcohol dehydrogenase in which nicotinamide adenine dinucleotide (NAD) serves a a coenzyme and in turn is reduced to its reduced form (NADH). The course and extent of the reaction are determined by ultraviolet colorimetry at 340 nanometers. at which wave length NAD does not absorb the ultraviolet light but NADH does.
In order for the reaction to be utilized in a practical assay it is necessary for the reaction to go to completion. and this. of course. is not insured by the presence of the enzyme and coenzyme alone. Rather. it is necessary to sequester or to trap in some fashion one of the reaction products. of which the most practical one is the acetaldehyde. Also. as indeed in most enzymatic reactions. the presence of a buffer is necessary to insure that a pH is maintained within the optimum range for that particular enzymatic reaction concerned.
A useful trapping agent has been found to be aminooxyacetic acid. described in connection with an ethanol assay in US. Pat. No. 3.493.467. of William Drell et al. and in Clinical Chemistry 16 402-407 (1970). in an article by Jones. Gerber and Drell.
Subsequent to the appearance of the Drell et al. publications just noted. it was found that aminooxyacetic acid apparently underwent a reaction with the NAD. leading to a blank absorbance which was subject to random variations. This difficulty was the subject of correspondence published in Clinical Chemistry l7.[5] 458460 (1971 I have now discovered that two closely related compounds. as well as mixtures of the two in any proportion. not only furnish the desired and requisite buffer capacity for an assay mixture based upon the enzymatic reaction set forth hereinabove. but enable the complete elimination of the aminooxyacetic acid. these compounds or mixtures of the two quite surprisingly serving as a trapping agent for the acetaldehyde generated by the reaction. Elimination of the aminooxyacetic acid leads to a stable assay mixture in which the blank absorbance is substantially constant and predictable and also enables a considerable simplification to be made in formulating the assay mixture since a single substance now serves two separate functions.
The two compounds are 2-amino-2-hydroxymethyl)- 1.3-propanediol'. and 2-amino-2-methyl- 1 .3- propanediol. The first of these is commonly known as "Trisamino"; and may also be namedas tris(hydroxymethyhaminomethane. it is entered on pagel083 of the Merck index. 8th edition 1968. under the generic" name of tromethamine. The second compound recited appears on page 57 of the Merck Index under the Geneva nomenclature given above. Both of these compounds. which as will be observed. differ only by one hydroxyl radical. give a pH somewhat in excess of 10 in diluted aqueous solution. When partially neutralized with acid. such as hydrochloric. to a pH within the general range of 8.9 to,9.2 then they behave as buffers with a good buffer capacity. and likewise exhibit the trapping effect already mentioned.
Any of the usual methods common in this art for putting together the individual components so as to form the inventive combination may be used. For example. all of the components may be put into a single solution. which may conveniently be water. and this may then be freeze dried followed by grinding or sieving so as to produce a dry powdered composition. Alternately. the components may be intimately mixed together in their dry state, for which ball milling is convenient. This brings about a homogeneous composition in the form of a fine powder. Still further. enhanced stability may be given to the combination by supplying it in two moieties. This may conveniently comprise the NAD as one moiety and the balance of the components as the second. In order to carry out the assay. preselected quantities of each are dissolved in water and mixed together. The fluid to be assayed for its ethanol content is added in a preselected volume. and the absorbance of the solution before and after incubation under selected conditions. typically for 8 to 10 minutes at 30 C. is determined. A blank is carried through the procedure in the usual fashion so that appropriate correction may be automatically made. The details of the actual absorbance procedure follow the customary sequence. and need not be set forth in detail here. A typical and recommendable protocol may be found in the Jones et al. 1970 article and in the Drell et al. patent cited here and above. both of which are included herein by reference. Of course. when the components are not provided as two moieties. but rather as a single mixture, then a preselected quantity of the single mixture is dissolved in water and the assay carried out as already described.
Some working examples will now be given.
EXAMPLE 1.
A dry blend is made of the following substances in the quantities named:
2-amino 2-hydroxymethyl-l .3- propanediol 842 mg. Succinic acid v 104 mg. Ethylene diamine tetra-acetic acid. tetrasodium salt 26 mg. Alcohol dehydrogenase 216 LU. NAD 17.2 mg. Milligrams lnternution al Units The foregoing ingredients are first separately dried by desiccation at room temperature. convenientlyover phosphorus pentoxide, and then dry blended to form the inventive composition. For use. 13.5 milliliters (ml) of water are added and the composition is permitted to dissolve. For carrying out the assay, a suitable quantity of body fluid such as 0.1 ml. of serum. saliva. or the like is diluted with 4.9 m1. of water or if preferred of isotonic saline (0.9% aqueous sodium chloride). This is mixed with the assay solution in the proportion of 0.1 ml. of the diluted serum or the like as already described and 2.6 ml of the assay solution. A blank is conveniently carried out in parallel fashion in which 0.1 ml of the saline solution alone is added to 2.6 ml of the assay solution. These operations are conveniently carried out by adding the solutions to a cuvet adapted to photometyll .3-propanediol.
' ted.
EXAMPLE 3.
The composition and procedures of Example I are carried out as stated except that in place of 842 mg'of 2-amino-2-hydroxymethyl- 1.3-propanediol there are used 421 mg of Z-aminO-Z-hydroxymethyl-1.3- propanediol together with 369 mg of 2-amino-2-meth- EXAMPLE 4.1 I
The composition and procedures of Example 1 are carried out as stated with the exception that the ethylene diamine tetra-acetic acid. tetrasodium salt. is omit- EXAMPLE 5." I I The-compositionand procedures of Example 2 are carried out as stated with the exception that the ethylene diamine tetra-acetic acid. tetrasodiu-m salt. is omitted.
EXAMPLE 6.
The composition and procedures of Example 3are carried out as stated with. the exception that the ethylene diamine tetra-acetic acid. tetrasodium salt. is omitted.
EXAMPLE 7.
The composition of Example l is prepared and dissolved in 13.5 ml of distilled water. The solution is then freeze-dried to yield a dry. homogeneous mixture. which is used for carrying out the assay'as already described in Example I. v
EXAMPLE 8.
The procedure of Example 7 is carried out as stated therein except that the composition of Example 4 instead-of the composition of Example 1 is used.
As regards relative proportion of the several compo-' 1. buffer/trapping agent 6.99
2. acid sufficient to give pH in range of m {9.2 3. alcohol dehydrogenase 200 220 1 LU.
4. NAD m-lx It will be readily appreciated that when the composition is varied within the limits set forth above then the assay solution should be calibrated by the use of a known quantity of dilute alcohol.
In any case. in order to achieve efficient trapping of the acetaldehyde produced during the enzymatic reaction. the buffer/trapping agent should be present in the assay mixture solution at aconcentration of at least 0.3 molar. An excess does no harm. but is of course waste- 5. heavy metal sequestrant .ful. A practical upper limit is 3 molar. although even this may be exceeded without affecting the inventive assay. I
As mentioned. both species of the buffer/trapping agent used in accordance with the invention have a natural-alkalinity somewhat higher than the optimum pH for the enzymatic reactionconcer'ned so that l in clude an acid in the inventive composition. Where the composition is prepared by mixing together dry ingredients then a solid acid is desirable. particularly one that does not have any water of crystallization in the molecule. Succinic acid is well adapted for this purpose and in general'[ find it best. Tartaric acid inany of its isomeric forms may likewise be used as well as other solid acids. such as. for example. fumaric. gluconic. citric. malic and the like. Where the assay composition is prepared by a preliminary dissolution and then freeze-dried. the acids already named may be used and non-solid'acids as well.such as hydrochloric. sulphuric. phosphoric and the like. The relative proportions of acid and buffer/trapping agent are selected-to give a pH in the range already stated when .the solid assay mixture is dissolved in water in such proportionasto give a molarity of at least 0.3 for the buffer/trapping agent. Needless to say. the weight proportion will vary depending on the particular acid or mixture ofacids selected. A typical weight ratio appears in the examples.
I prefer and find it best to select components which are entirely free of any contamination by heavy metal ions. It is sometimes difficult to find commercial sources of the buffer/trapping agents disclosed which are sufficiently pure in this regard although. of course. they may be purified by anyone wishing to practise the invention. By way of a safeguard. accordingly. I find it convenient to include a heavy metal sequestrant in the inventive composition. even when it is believed that the individual components are sufficiently pure. Indeed, in any case this guards against nickel. chromium or iron ions which might inadvertently be introduced if the user employs water which had been in contact with stainless .steel. The heavy metal sequestrant which l prefer and find best is ethylene diamine tetra-acetic acid, which may be added as an acid or as any of its sodium salts. The amount used is small in any case. so that whether it is added as the acid or salt form is not critical particularly since any acid contribution therefrom will automatically be compensated for when a determination-is made of. the quantity of the selected acid needed to achieve a pH in the stated range. Many other heavy metal sequestrants may be employed. such as. for example. diethyline triamine penta-acetic acid; S-hydroxyquinoline; orthophenanthroline; bipyridyl; and many others known to those skilled in the art of coordination chemistry. The sequestrant may typically be employed in quantities of from about 1 to 5 parts per 100 of the buffer/trapping agent.
It will be understood that while I have explained the invention with the aid of specific examples. nevertheless considerable variation is' possible in choice of materials, proportions, reaction conditions, and the like. with the broad scope of the invention as set forth in the claims that follow.
Having disclosed the invention, I claim:
1. A composition of matter useful as a reagent in determining the ethanol content of body fluids consisting essentially of:
a. the enzyme alcohol dehydrogenase;
b. the coenzyme nicotinamide adenine dinucleotide;
c. a buffer/acetaldehyde-trapping agent selected from the group consisting of Z-amino-Z-hydroxymethyll .3-propanediol, 2-amino-2-methyl- 1,3- propanediol and mixtures thereof;
d. an acid in quantity sufficient to lower the pH of an aqueous solution of said mixture to within the range of about 8.8 to 9.2;
said mixture being free of any other acetaldehyde trapping agent.
2. The composition of claim 1 wherein said composition is present in the form of two moieties. one containing said coenzyme and the other the balance of the recited components.
3. The composition of claim 1 which includes a heavy metal sequestering agent.
4. The composition of claim 3 in which said sequestering agent is ethylene diamine tetra-acetic acid. or a sodium salt thereof.
5. An assay solution useful in the determination of the ethanol content of body fluids consisting essentially of the composition of claim 1 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of at least 0.3 molar.
6. A composition in accordance with claim 1 wherein, for each 6.99 millimoles of said buffer/trapping agent, l6 18 mg of NAD; and from 200 220 LU. of alcohol dehydrogenase are present.
7. An assay solution useful in the determination of the ethanol content of body fluids consisting essentially of the composition of claim 6 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of approximately at least 0.3 molar.
Claims (7)
1. A COMPOSITION OF MATTER AS A REAGENT IN DETERMINING THE ETHANOL CONTENT OF BODY FLUIDS CONSISTING ESSENTIALLY OF: A. THE ENZYME ALCOHOL DEHYDROGENASE; B. THE COENZYME NICTINAMIDE ADENINE DINUCLEOTIDE; C. A BUFFER/ACTEALDEHYDR-TRAPPING AGENT SELECTED FROM THE GROUP CONSISTING OF 2-AMINO-2-HYDROXYMETHYL-1,3PROPANEDIOL, 2-AMINO-2-METHYL-1,3-PROPANEDIOL AND MIXTURES THEREOF; D. AM ACID IN QUANTITY SUFFICIENT TO LOWER THE PH OF AN AQUEOUS SOLUTION OF SAID MIXTURE TO WITHIN THE RANGE OF ABOUT 8.8 TO 9.2; SAID MIXTURE BEING FREE OF ANY OTHER ACETALDEHYDE TRAPPING AGENT.
2. The composition of claim 1 wherein said composition is present in the form of two moieties, one containing said coenzyme and the other the balance of the recited components.
3. The composition of claim 1 which includes a heavy metal sequestering agent.
4. The composition of claim 3 in which said sequestering agent is ethylene diamine tetra-acetic acid, or a sodium salt thereof.
5. An assay solution useful in the determination of the ethanol content of body fluids consisting essentially of the composition of claim 1 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of at least 0.3 molar.
6. A composition in accordance with claim 1 wherein, for each 6.99 millimoles of said buffer/trapping agent, 16 - 18 mg of NAD; and from 200 - 220 I.U. of alcohol dehydrogenase are present.
7. An assay solution useful in the determination of the ethanol content of boDy fluids consisting essentially of the composition of claim 6 dissolved in sufficient water to provide a concentration of said buffer/trapping agent of approximately at least 0.3 molar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US502210A US3926736A (en) | 1974-08-30 | 1974-08-30 | Enzymatic ethanol assay |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US502210A US3926736A (en) | 1974-08-30 | 1974-08-30 | Enzymatic ethanol assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3926736A true US3926736A (en) | 1975-12-16 |
Family
ID=23996831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US502210A Expired - Lifetime US3926736A (en) | 1974-08-30 | 1974-08-30 | Enzymatic ethanol assay |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3926736A (en) |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338395A (en) * | 1980-07-21 | 1982-07-06 | Technicon Instruments Corporation | Method for the analysis of triglycerides |
| WO1983002953A1 (en) * | 1982-02-19 | 1983-09-01 | Endotronics Inc | Process and apparatus for controlling patterns of chemicals stimuli administration to biological tissue |
| US4476222A (en) * | 1982-08-02 | 1984-10-09 | Eiken Kagaku Kabushiki Kaisha | Test piece for quantitative analysis of substances in body fluids |
| US4734360A (en) * | 1983-07-12 | 1988-03-29 | Lifescan, Inc. | Colorimetric ethanol analysis method and test device |
| US4810633A (en) * | 1984-06-04 | 1989-03-07 | Miles Inc. | Enzymatic ethanol test |
| US5141854A (en) * | 1990-12-13 | 1992-08-25 | Hoffman-La Roche, Inc. | Enzymatic composition for ethanol assay |
| US5196302A (en) * | 1990-08-29 | 1993-03-23 | The United States Of America As Represented By The Sectetary Of The Navy | Enzymatic assays using superabsorbent materials |
| US5290683A (en) * | 1992-11-19 | 1994-03-01 | Yedy Israel | Rapid analysis of ethanol in body fluids |
| US5416004A (en) * | 1993-01-19 | 1995-05-16 | Detwiler; Richard L. | Multilayer analytical element containing primary amine buffer and method for the determination of ethanol |
| US5426032A (en) * | 1986-08-13 | 1995-06-20 | Lifescan, Inc. | No-wipe whole blood glucose test strip |
| US5429932A (en) * | 1993-05-24 | 1995-07-04 | Eastman Kodak Company | Multilayer analytical element containing niacinamide and method for the determination of ethanol |
| US5429931A (en) * | 1993-05-24 | 1995-07-04 | Eastman Kodak Company | Multilayer analytical element containing crosslinked binder and method for the determination of ethanol |
| WO2001062838A2 (en) * | 2000-02-22 | 2001-08-30 | The Coca-Cola Company | Method to decrease the acetaldehyde content of melt-processed polyesters |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US6632874B2 (en) | 2001-05-01 | 2003-10-14 | The Coca-Cola Company | Method to decrease aldehyde content in polyolefin products |
| US6686336B2 (en) | 2000-02-08 | 2004-02-03 | Federal Government As Represented By The Department Of Veterans Affaires | N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents |
| US6762275B1 (en) | 2003-05-27 | 2004-07-13 | The Coca-Cola Company | Method to decrease the acetaldehyde content of melt-processed polyesters |
| US20050049391A1 (en) * | 2003-08-28 | 2005-03-03 | Mark Rule | Polyester composition and articles with reduced acetaldehyde content and method using vinyl esterification catalyst |
| US7041350B1 (en) | 2002-08-30 | 2006-05-09 | The Coca-Cola Company | Polyester composition and articles with reduced acetaldehyde content and method using hydrogenation catalyst |
| US20070031914A1 (en) * | 2005-08-05 | 2007-02-08 | Wei Zhu | Devices for analyte assays and methods of use |
| WO2007134683A1 (en) * | 2006-05-22 | 2007-11-29 | Merck Patent Gmbh | Method and means for the enzymatic determination of ethanol |
| CN1987474B (en) * | 2006-07-13 | 2012-04-18 | 重庆医科大学 | Disposable biosensor to detect blood alcohol concentration |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3413198A (en) * | 1966-06-30 | 1968-11-26 | Calbiochem | Reagents and method for assaying biological samples |
| US3493467A (en) * | 1967-07-26 | 1970-02-03 | Smithkline Corp | Reversible biochemical reaction employing a trapping agent |
| US3764478A (en) * | 1969-06-13 | 1973-10-09 | Boehringer Mannheim Gmbh | Stabilized enzymatic test reagents |
-
1974
- 1974-08-30 US US502210A patent/US3926736A/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3413198A (en) * | 1966-06-30 | 1968-11-26 | Calbiochem | Reagents and method for assaying biological samples |
| US3493467A (en) * | 1967-07-26 | 1970-02-03 | Smithkline Corp | Reversible biochemical reaction employing a trapping agent |
| US3764478A (en) * | 1969-06-13 | 1973-10-09 | Boehringer Mannheim Gmbh | Stabilized enzymatic test reagents |
Cited By (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338395A (en) * | 1980-07-21 | 1982-07-06 | Technicon Instruments Corporation | Method for the analysis of triglycerides |
| WO1983002953A1 (en) * | 1982-02-19 | 1983-09-01 | Endotronics Inc | Process and apparatus for controlling patterns of chemicals stimuli administration to biological tissue |
| US4476222A (en) * | 1982-08-02 | 1984-10-09 | Eiken Kagaku Kabushiki Kaisha | Test piece for quantitative analysis of substances in body fluids |
| US4734360A (en) * | 1983-07-12 | 1988-03-29 | Lifescan, Inc. | Colorimetric ethanol analysis method and test device |
| US4810633A (en) * | 1984-06-04 | 1989-03-07 | Miles Inc. | Enzymatic ethanol test |
| US5426032A (en) * | 1986-08-13 | 1995-06-20 | Lifescan, Inc. | No-wipe whole blood glucose test strip |
| US6858401B2 (en) | 1986-08-13 | 2005-02-22 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US6821483B2 (en) | 1986-08-13 | 2004-11-23 | Lifescan, Inc. | Reagents test strip with alignment notch |
| US5843692A (en) * | 1986-08-13 | 1998-12-01 | Lifescan, Inc. | Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood |
| US6881550B2 (en) | 1986-08-13 | 2005-04-19 | Roger Phillips | Method for the determination of glucose employing an apparatus emplaced matrix |
| US6887426B2 (en) | 1986-08-13 | 2005-05-03 | Roger Phillips | Reagents test strip adapted for receiving an unmeasured sample while in use in an apparatus |
| US6268162B1 (en) | 1986-08-13 | 2001-07-31 | Lifescan, Inc. | Reflectance measurement of analyte concentration with automatic initiation of timing |
| US5563042A (en) * | 1986-08-13 | 1996-10-08 | Lifescan, Inc. | Whole blood glucose test strip |
| US5196302A (en) * | 1990-08-29 | 1993-03-23 | The United States Of America As Represented By The Sectetary Of The Navy | Enzymatic assays using superabsorbent materials |
| US5141854A (en) * | 1990-12-13 | 1992-08-25 | Hoffman-La Roche, Inc. | Enzymatic composition for ethanol assay |
| US5525481A (en) * | 1990-12-13 | 1996-06-11 | Hoffman-La Roche Inc. | Enzymatic Reagents for ethanol assay containing diamino compounds |
| US5290683A (en) * | 1992-11-19 | 1994-03-01 | Yedy Israel | Rapid analysis of ethanol in body fluids |
| US5416004A (en) * | 1993-01-19 | 1995-05-16 | Detwiler; Richard L. | Multilayer analytical element containing primary amine buffer and method for the determination of ethanol |
| US5429931A (en) * | 1993-05-24 | 1995-07-04 | Eastman Kodak Company | Multilayer analytical element containing crosslinked binder and method for the determination of ethanol |
| US5429932A (en) * | 1993-05-24 | 1995-07-04 | Eastman Kodak Company | Multilayer analytical element containing niacinamide and method for the determination of ethanol |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US6979571B2 (en) | 1999-11-24 | 2005-12-27 | Home Diagnostics, Inc. | Method of using a protective test strip platform for optical meter apparatus |
| US6686336B2 (en) | 2000-02-08 | 2004-02-03 | Federal Government As Represented By The Department Of Veterans Affaires | N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents |
| WO2001062838A3 (en) * | 2000-02-22 | 2002-03-07 | Coca Cola Co | Method to decrease the acetaldehyde content of melt-processed polyesters |
| WO2001062838A2 (en) * | 2000-02-22 | 2001-08-30 | The Coca-Cola Company | Method to decrease the acetaldehyde content of melt-processed polyesters |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US7390665B2 (en) | 2001-02-28 | 2008-06-24 | Gilmour Steven B | Distinguishing test types through spectral analysis |
| US6632874B2 (en) | 2001-05-01 | 2003-10-14 | The Coca-Cola Company | Method to decrease aldehyde content in polyolefin products |
| US7041350B1 (en) | 2002-08-30 | 2006-05-09 | The Coca-Cola Company | Polyester composition and articles with reduced acetaldehyde content and method using hydrogenation catalyst |
| US6762275B1 (en) | 2003-05-27 | 2004-07-13 | The Coca-Cola Company | Method to decrease the acetaldehyde content of melt-processed polyesters |
| US20050049391A1 (en) * | 2003-08-28 | 2005-03-03 | Mark Rule | Polyester composition and articles with reduced acetaldehyde content and method using vinyl esterification catalyst |
| US20070031914A1 (en) * | 2005-08-05 | 2007-02-08 | Wei Zhu | Devices for analyte assays and methods of use |
| WO2007134683A1 (en) * | 2006-05-22 | 2007-11-29 | Merck Patent Gmbh | Method and means for the enzymatic determination of ethanol |
| CN1987474B (en) * | 2006-07-13 | 2012-04-18 | 重庆医科大学 | Disposable biosensor to detect blood alcohol concentration |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3926736A (en) | Enzymatic ethanol assay | |
| Davison | Studies on plant formic dehydrogenase | |
| US3413198A (en) | Reagents and method for assaying biological samples | |
| Quayle et al. | Carbon assimilation by Pseudomonas oxalaticus (OX 1). 2. Formate and carbon dioxide utilization by cell-free extracts of the organism grown on formate | |
| Beers | Enzymic synthesis and properties of a polynucleotide from adenosine diphosphate | |
| Berger et al. | Dehydrogenases of the Avena coleoptile | |
| US3527674A (en) | Reagent material and method for urea assay | |
| JPS5934119B2 (en) | Composition for measuring creatine kinase | |
| US4465770A (en) | Stabilized enzymic solutions for determining urea | |
| Kuczenski et al. | Interactions of Fructose 1, 6-diphosphate, substrates, and monovalent cations with yeast pyruvate kinase monitored by changes in enzyme fluorescence | |
| GB2028500A (en) | Method for determining a transminase in a biological fluid and reagent combinations for use in the methods | |
| Spizizen et al. | Biochemical studies on the phenomenon of virus reproduction: III. The inhibition of coliphage T2r+ multiplication by sodium salicylate and sodium gentisate | |
| JPH0154997B2 (en) | ||
| CA1045961A (en) | Enzymatic ethanol assay | |
| US3528888A (en) | Reagent and method for assaying alpha-hydroxybutyrate dehydrogenase | |
| Izutsu et al. | Properties of the HCO 3−-stimulated Mg 2+-ATPase activity in red cell membranes | |
| JPS6231912B2 (en) | ||
| WO1984004931A1 (en) | Method and composition for determination of gamma glutamyl transpeptidase | |
| US3573171A (en) | Laboratory reagent for assay of lactic acid | |
| EP0721986A2 (en) | Creatine kinase reagent | |
| US5721111A (en) | Method for determination of urea nitrogen | |
| Klotzsch et al. | Inhibitor-contaminated NADH: its influence on dehydrogenases and dehydrogenase-coupled reactions | |
| JPS59151899A (en) | Determination composition | |
| JP3146692B2 (en) | Alkaline phosphatase assay reagent and assay method using the same | |
| US3616257A (en) | Reagent for assaying thyromimetric compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: AMERICAN HOECHST CORPORATION Free format text: MERGER;ASSIGNOR:CALBIOCHEM-BEHRING CORP.;REEL/FRAME:004093/0784 Effective date: 19820916 Owner name: AMERICAN HOECHST CORPORATION, STATELESS Free format text: MERGER;ASSIGNOR:CALBIOCHEM-BEHRING CORP.;REEL/FRAME:004093/0784 Effective date: 19820916 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED FILE - (OLD CASE ADDED FOR FILE TRACKING PURPOSES) |
